London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Folks just a thank you from me. That thread has been greatly informative. I'm already invested in SAR which is having a stellar couple of weeks and this stock is looking like it's got similar potential. Covid short term but also long term value.
Chances of trail coming good though??
Everything is lined up for a substantial rise here but we should be a bit patient , IMO
Holding for gold ...
a guy started an evg telegram chat.. small but growing fast
https://tinyurl.com/y5fkofpw
Lol cashfornuthin, exactly right mate, i've always enjoyed the chase and flying the flag of any stock i think has muti-bag potential and prospects, and especially enjoy the cut and thrust of opposing views from those intent to undermine , and so more than happy to see a surge of new investors with positive opinion, rather than just mine and a few others, which obviously suggests that Evgen is all set for its next exciting devlopment phase with significant UPside and substantial value on its way...Gl ;-)
Mm...you will be able to take some time off now and let others do the talking. .going to get very busy here... :)
£1 will do well, before Big Pharma will take a swipe and that could be multiples IMO
Summer fun,
£ 10 ??
Let’s get to £1 first before we get too excited :-)
Massive undoubted UPside potential from Evgen's lowly market cap especially compared to other Bios' with similar stage pipelines valued many £millions more, Phase 2/3 for Covid and outstanding Phase 2 results for breast cancer, which are in the planning for phase 2b patient trials and compelling clinical data on a host of other disease targets currently in evaluation by high profile academia for consideration to progress to patient trials in CKD, NASH, Autism etc , not to mention the potential of the non-pharma market with Jim Mellon's £250k investment via his Juvenscene development company which develops therapies that will allow people worldwide to live longer, healthier lives, £10.5m milestones and royalties thereafter....incredible prospects and potential from a little gem of a company, which amazingly still appears very much under the radar at the moment and rediculously undervalued.....Sooner or later this will go BIG time imho....Gla ;-)
Agree crazy that I can buy more down here
Something must be holding this back distressed seller maybe
Otherwise this should be at least 30-40p plus already
Still think a re-rate is due here. Not sure what's holding it back. Aren't many stocks with a potential COVID treatment going for under £20m.
An orderly share transfer and accumulation is in progress imho, and those that have parted with their shares cheaply will well and truly wish they hadn't in due course...maybe a strategic investor and/or JV is on the cards, and would be no surprise given SFX-01's panacea potential over multiple disease targets which must be of great interest to Big Pharma...Gla :-)
As far as any stellar rise on SFX-01's Covid-19 patient trials, then obviously that will not happen until positive results are reported, and although Top line results aren't expected until well into next year, early reporting is very likely given that it is a phase 2 and phase 3 trial combined, whereby phase 2 results could be reported by the end of the year, if not sooner. SFX-01 was selected from over 130 drug application candidates because of its activation potency of the Nrf2 pathway which is thought to be key in regulating the expression of antioxidant proteins that protect against oxidative damage triggered by injury and inflammation, associated with multiple diseases including respiratory infections and distress associated with Covid-19, ARDS and pneumonia. SFX-01 is also a potent activator of the STAT3 pathway, which has been confirmed recently as the "key to immune system inflammation " and has been targeted for the treatment of cancer, including SFX-01 phase 2 breast cancer trials , where results were outstanding and life changing for some patients, and has been recently recommended for clinical development for the treatment of Covid-19, and so SFX-01's dual mechanism over these 2 key pathways must increase the chances of its potential in becoming a therapeutic benefit and treatment for Covid-19, ARDS , Pneumonia etc, as well as a host of other diseases and infections that are thought to be influenced by Nrf2 and Stat3 pathways. Lots to look forward to with great excitement with news possible at anytime on multiple fronts. Gla :-)
Some CHUCKY buys going through:-
11:42:53 14.00 249,903 34.99k
This is big news by the way:
"Patients may therefore be drawn from both hospital and community settings and may present with COVID -19 or other respiratory diseases. It is a randomised, placebo-controlled trial and is sponsored by the University of Dundee."
Don't have to rely on just hospital patients and don't have to wait for confirmation of COVID-19. This should allow for rapid recruitment and early indications of results.
This share is undervalued and that is what MM is trying to get across. When will the market wake up to this. Meanwhile you have people like Kingalf saying only yesterday no news until December. Why don't you say anything about him?
Moneymunch,
Whilst I don’t like your pumping , I think we have a good chance here with the science .... it would not surprise me if the company was to be sold in the months / years to come at many times the current market cap ....
All to be confirmed of course but definitely a LT hold IMO
Looking at the trades today some massive buys in there, so some accumulations going on there. Sells look to be small trades, so PIs selling on the back of their 10 - 15% gains.
Finncap (Evgen's broker )have been collecting shares on the cheap for months now I reckon, massive share transfers and accumulation in progress imho....very likely for a high profile customer...Watch this Space!!!.....the potential bargain of the century from this current lowly market cap...:-)
King Alf,
Look again at the market cap , and you will see that not much is priced in here ...IMV
Lol...shut it kingelf...you desperate clown...ha ha ha :-)
Of course it is new news. Reg approvals given and also community settings as well as hospital...initially was to be in hospital only..so both in one go..
Let's not get ahead of ourselves here.
They've basically announced the start of something most us us thought they had already started.
This is not new news, this info was already priced into the share value.
Huge . I think this goes 20p plus very fast as word spreads and people see how cheap this is at these levels
This is so undervalued I think 30p plus comes very fast here
Once on the radar this will move rapidly
Loading up
Breast Cancer clinical trials on BBC TV news now, discussing new drugs prolonging the life of terminally patients at Christies Hospital , Manchester.....one of the previous trial sites for SFX-01 in collaboration with University of Manchester. Gla ;-)